IL-17A-mediated expression of epithelial IL-17C promotes inflammation during acute Pseudomonas aeruginosa pneumonia

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 311, Issue 5, 2016, Pages L1015-L1022

  Wolf, Lisa ^a   Sapich, Sandra ^b   Honecker, Anja ^a   Jungnickel, Christopher ^a   Seiler, Frederik ^a   Bischoff, Markus ^a   Wonnenberg, Bodo ^a   Herr, Christian ^a   Schneider Daum, Nicole ^b   Lehr, Claus Michael ^b,c   Bals, Robert ^a   Beisswenger, Christoph ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

IL 17A; IL 17C; Inflammation; P. aeruginosa; Pathology; Pneumonia; Sepsis

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17C; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIABILITY; CONTROLLED STUDY; IMMUNOCOMPETENT CELL; INFLAMMATORY CELL; LEUKOCYTE DIFFERENTIAL COUNT; LUNG ALVEOLUS EPITHELIUM CELL; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; LYMPHOID CELL; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PNEUMONIA; SEPSIS; ANIMAL; C57BL MOUSE; COMPLICATION; KNOCKOUT MOUSE; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHYSIOLOGY; PNEUMONIA; SURVIVAL ANALYSIS;

ALVEOLAR EPITHELIAL CELLS; ANIMALS; INTERLEUKIN-17; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROBIAL VIABILITY; NEUTROPHIL INFILTRATION; PNEUMONIA; PSEUDOMONAS AERUGINOSA; SURVIVAL ANALYSIS;

EID: 84995486689     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00158.2016     Document Type: Article

References (39)

1. Beisswenger C, Honecker A, Kamyschnikow A, Bischoff M, Tschernig T, Bals R. Moxifloxacin modulates inflammation during murine pneumonia. Respir Res 15: 82, 2014.
2. Butcher MJ, Waseem TC, Galkina EV. Smooth muscle cell-derived interleukin-17C plays an atherogenic role via the recruitment of proinflammatory interleukin-17A+ T cells to the aorta. Arterioscler Thromb Vasc Biol 36: 1496–1506, 2016.
3. Chang SH, Reynolds JM, Pappu BP, Chen G, Martinez GJ, Dong C. Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E. Immunity 35: 611–621, 2011.
4. Cohen-Cymberknoh M, Kerem E, Ferkol T, Elizur A. Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications. Thorax 68: 1157–1162, 2013.
5. Cohen TS, Prince AS. Activation of inflammasome signaling mediates pathology of acute P. aeruginosa pneumonia. J Clin Invest 123: 1630– 1637, 2013.
6. Daum N, Kuehn A, Hein S, Schaefer UF, Huwer H, Lehr CM. Isolation, cultivation, and application of human alveolar epithelial cells. Methods Mol Biol 806: 31–42, 2012.
7. Demaio L, Tseng W, Balverde Z, Alvarez JR, Kim KJ, Kelley DG, Senior RM, Crandall ED, Borok Z. Characterization of mouse alveolar epithelial cell monolayers. Am J Physiol Lung Cell Mol Physiol 296: L1051–L1058, 2009.
8. Dubin PJ, Martz A, Eisenstatt JR, Fox MD, Logar A, Kolls JK. Interleukin-23-mediated inflammation in Pseudomonas aeruginosa pulmonary infection. Infect Immun 80: 398–409, 2012.
9. Eber E, Zach MS. Pseudomonas aeruginosa infection in cystic fibrosis: prevent, eradicate or both? Thorax 65: 849–851, 2010.
10. Friedrich M, Diegelmann J, Schauber J, Auernhammer CJ, Brand S. Intestinal neuroendocrine cells and goblet cells are mediators of IL-17A-amplified epithelial IL-17C production in human inflammatory bowel disease. Mucosal Immunol 8: 943–958, 2015.
11. Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 9: 556–567, 2009.
12. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123–1132, 2005.
13. Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate immune system. Nat Immunol 16: 343–353, 2015.
14. Kim SR, Kim HJ, Kim DI, Lee KB, Park HJ, Jeong JS, Cho SH, Lee YC. Blockade of interplay between IL-17A and endoplasmic reticulum stress attenuates LPS-induced lung injury. Theranostics 5: 1343–1362, 2015.
15. Koulenti D, Lisboa T, Brun-Buisson C, Krueger W, Macor A, Sole-Violan J, Diaz E, Topeli A, DeWaele J, Carneiro A, Martin-Loeches I, Armaganidis A, Rello J; EU-VAP/CAP Study Group. Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med 37: 2360–2368, 2009.
16. Kusagaya H, Fujisawa T, Yamanaka K, Mori K, Hashimoto D, Enomoto N, Inui N, Nakamura Y, Wu R, Maekawa M, Suda T, Chida K. Toll-like receptor-mediated airway IL-17C enhances epithelial host defense in an autocrine/paracrine manner. Am J Respir Cell Mol Biol 50: 30–39, 2014.
17. Li JT, Melton AC, Su G, Hamm DE, LaFemina M, Howard J, Fang X, Bhat S, Huynh KM, O’Kane CM, Ingram RJ, Muir RR, McAuley DF, Matthay MA, Sheppard D. Unexpected role for adaptive alpha-betaTh17 cells in acute respiratory distress syndrome. J Immunol 195: 87–95, 2015.
18. Lu YJ, Gross J, Bogaert D, Finn A, Bagrade L, Zhang Q, Kolls JK, Srivastava A, Lundgren A, Forte S, Thompson CM, Harney KF, Anderson PW, Lipsitch M, Malley R. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 4: e1000159, 2008.
19. Medzhitov R. Origin and physiological roles of inflammation. Nature 454: 428–435, 2008.
20. Miyamoto M, Prause O, Sjostrand M, Laan M, Lotvall J, Linden A. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol 170: 4665–4672, 2003.
21. Muir R, Osbourn M, Dubois AV, Doran E, Small DM, Monahan A, O’Kane CM, McAllister K, Fitzgerald DC, Kissenpfennig A, McAuley DF, Ingram RJ. Innate lymphoid cells are the predominant source of interleukin-17A during the early pathogenesis of acute respiratory distress syndrome. Am J Respir Crit Care Med 193: 407–416, 2016.
22. Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I, Sekikawa K, Asano M, Iwakura Y. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375–387, 2002.
23. Pfeifer P, Voss M, Wonnenberg B, Hellberg J, Seiler F, Lepper PM, Bischoff M, Langer F, Schafers HJ, Menger MD, Bals R, Beisswenger C. IL-17C is a mediator of respiratory epithelial innate immune response. Am J Respir Cell Mol Biol 48: 415–421, 2013.
24. Pfeifer P, Voss M, Wonnenberg B, Hellberg J, Seiler F, Lepper PM, Bischoff M, Langer F, Schafers HJ, Menger MD, Bals R, Beisswenger C. IL-17C is a mediator of respiratory epithelial innate immune response. Am J Respir Cell Mol Biol 48: 415–412, 2013.
25. Ramirez-Carrozzi V, Sambandam A, Luis E, Lin Z, Jeet S, Lesch J, Hackney J, Kim J, Zhou M, Lai J, Modrusan Z, Sai T, Lee W, Xu M, Caplazi P, Diehl L, de Voss J, Balazs M, Gonzalez L Jr, Singh H, Ouyang W, Pappu R. IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat Immunol 12: 1159–1166, 2011.
26. Reppe K, Radunzel P, Dietert K, Tschernig T, Wolff T, Hammerschmidt S, Gruber AD, Suttorp N, Witzenrath M. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection. Infect Immun 83: 4617–4629, 2015.
27. Schultz MJ, Rijneveld AW, Florquin S, Edwards CK, Dinarello CA, van der Poll T. Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia. Am J Physiol Lung Cell Mol Physiol 282: L285–L290, 2002.
28. Seiler F, Lepper PM, Bals R, Beisswenger C. Regulation and function of antimicrobial peptides in immunity and diseases of the lung. Protein Pept Lett 21: 341–351, 2014.
29. Song C, Luo L, Lei Z, Li B, Liang Z, Liu G, Li D, Zhang G, Huang B, Feng ZH. IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol 181: 6117–6124, 2008.
30. Song X, Zhu S, Shi P, Liu Y, Shi Y, Levin SD, Qian Y. IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens. Nat Immunol 12: 1151–1158, 2011.
31. Tan HL, Rosenthal M. IL-17 in lung disease: friend or foe? Thorax 68: 788–790, 2013.
32. Voss M, Wolf L, Kamyschnikow A, Wonnenberg B, Honecker A, Herr C, Lepper PM, Wegmann M, Menger MD, Bals R, Beisswenger C. Il-17A contributes to maintenance of pulmonary homeostasis in a murine model of cigarette smoke-induced emphysema. Am J Physiol Lung Cell Mol Physiol 309: L188–L195, 2015.
33. Voss M, Wonnenberg B, Honecker A, Kamyschnikow A, Herr C, Bischoff M, Tschernig T, Bals R, Beisswenger C. Cigarette smoke-promoted acquisition of bacterial pathogens in the upper respiratory tract leads to enhanced inflammation in mice. Respir Res 16: 41, 2015.
34. Whitsett JA, Alenghat T. Respiratory epithelial cells orchestrate pulmonary innate immunity. Nat Immunol 16: 27–35, 2015.
35. Williams BJ, Dehnbostel J, Blackwell TS. Pseudomonas aeruginosa: host defence in lung diseases. Respirology 15: 1037–1056, 2010.
36. Wolbeling F, Munder A, Kerber-Momot T, Neumann D, Hennig C, Hansen G, Tummler B, Baumann U. Lung function and inflammation during murine Pseudomonas aeruginosa airway infection. Immunobiology 216: 901–908, 2011.
37. Wonnenberg B, Tschernig T, Voss M, Bischoff M, Meier C, Schirmer SH, Langer F, Bals R, Beisswenger C. Probenecid reduces infection and inflammation in acute Pseudomonas aeruginosa pneumonia. Int J Med Microbiol 304: 725–729, 2014.
38. Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RJ. Human IL-17: a novel cytokine derived from T cells. J Immunol 155: 5483–5486, 1995.
39. Zhang Z, Clarke TB, Weiser JN. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 119: 1899–1909, 2009.